These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 6982477)

  • 1. Proglumetacin (protacine): a promising new treatment of the rheumatic joint.
    Rivera IC
    Pharmatherapeutica; 1982; 3(3):169-73. PubMed ID: 6982477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Short-term and long-term open evaluation of the efficacy and tolerance of proglumetacin, a new antirheumatic agent.
    Branco do Amaral A
    Pharmatherapeutica; 1982; 3(3):174-9. PubMed ID: 6982478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Maintenance therapy of rheumatoid arthritis and of osteoarthrosis with proglumetacin.
    Bozsóky S; Zahumenszky Z
    Pharmatherapeutica; 1983; 3(5):305-13. PubMed ID: 6844368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Proglumetacin for the treatment of inflammatory and degenerative arthropathies].
    Tonon R; Simioni M; Lazzarin P; Bedendo A; Todesco S
    Minerva Med; 1984 May; 75(20):1189-92. PubMed ID: 6728268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Joint pain crises and chronic inflammatory-reactive phenomena: a unitary approach with proglumetacin].
    Larosa F; Vittore D; Mazzarisi A; Molfetta L
    Minerva Med; 1983 Jun; 74(26):1535-8. PubMed ID: 6856165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Proglumetacin: a flexible and broad-spectrum antirheumatic agent].
    Fontanesi G; Giancecchi F; Rotini R; Tartaglia I
    Minerva Med; 1983 Jun; 74(26):1547-51. PubMed ID: 6602308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Short-term study of proglumetacin].
    Zanoli S; Pace N; Raffaelli P
    Minerva Med; 1983 Jun; 74(26):1543-5. PubMed ID: 6222271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Proglumetacin for fast and safe control of joint pain of orthopedic importance].
    Lorenzi GL; Bertini G; Peveraro A
    Minerva Med; 1983 Jun; 74(26):1569-72. PubMed ID: 6856167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preliminary double-blind evaluation of a new, non-steroidal anti-inflammatory drug: protacine.
    Münzenberg J; Tachibana S
    Pharmatherapeutica; 1980; 2(5):279-84. PubMed ID: 7001486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Double-blind clinical trial of protacine versus oxyphenbutazone in rheumatic disorders.
    Loizzi P; Pipitone V; Bignamini AA
    Pharmatherapeutica; 1980; 2(5):285-92. PubMed ID: 7001487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Preliminary observations on the clinical use of the glucosamide of N-p-chlorobenzoyl-2-methyl-5-methoxy-indol-3-acetic acid monohydrate].
    Montini M; Ongaro A; Pagani G
    Reumatismo; 1972; 24(1):57-68. PubMed ID: 4546498
    [No Abstract]   [Full Text] [Related]  

  • 12. [Short-term effects of proglumetacin in arthrosis].
    Marcolongo R; Giordano N; Fioravanti A
    Minerva Med; 1983 Jun; 74(26):1521-4. PubMed ID: 6856163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Tolerance and efficacy of proglumetacine in patients with rheumatoid arthritis].
    Murelli M; Lignière GC
    Minerva Med; 1984 May; 75(19):1141-5. PubMed ID: 6728264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Proglumetacin for a wide spectrum of activity in clinical medicine].
    Fossaluzza V
    Minerva Med; 1983 Jun; 74(26):1529-33. PubMed ID: 6856164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A 3-month, double-blind study of proglumetacin and naproxen in the treatment of rheumatoid arthritis.
    Bozsoky S; Zahumenszky Z
    Curr Med Res Opin; 1982; 8(2):89-96. PubMed ID: 7049588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Proglumetacin: possible first choice in the treatment of orthopedic- traumatologic disorders].
    Gusso MI; Guzzo GC; Pennisi M
    Minerva Med; 1985 Mar; 76(12):567-73. PubMed ID: 3887221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proglumetacin in arthritis of the hip and the knee. Results of a post-marketing surveillance study.
    Carratelli L; Antonini P; Messina E; Pica B
    Drugs Exp Clin Res; 1985; 11(4):307-16. PubMed ID: 3836132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Double-blind evaluation of low-dose proglumetacin versus naproxen in rheumatoid arthritis out-patients.
    Espŕito Santo J; da Silva JP; da Costa JT; Gomes JM; Queiroz MV
    Curr Med Res Opin; 1983; 8(7):524-30. PubMed ID: 6354607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinico-statistical study on the anti-inflammatory activity of proglumetacin. Proglumetacin: at last a complete anti-inflammatory agent?].
    Benvenuti M; Albanese L; Pagliara L
    Minerva Med; 1983 Jun; 74(26):1563-8. PubMed ID: 6602310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Proglumetacin: a simple and practical anti-inflammatory agent for the treatment of hospitalized orthopedic patients].
    Ardito S; Leonardi W; Longo G
    Minerva Med; 1983 Jun; 74(26):1553-7. PubMed ID: 6856166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.